Report overview
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
This report aims to provide a comprehensive presentation of the global market for Anthrax Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthrax Vaccines. This report contains market size and forecasts of Anthrax Vaccines in global, including the following market information:
Global Anthrax Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anthrax Vaccines Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Anthrax Vaccines companies in 2022 (%)
The global Anthrax Vaccines market was valued at US$ 674 million in 2022 and is projected to reach US$ 1101.7 million by 2029, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
We surveyed the Anthrax Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthrax Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, by Type, 2022 (%)
Live Vaccines
Cell free PA Vaccines
Global Anthrax Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, by Application, 2022 (%)
Human Use
Animal Use
Global Anthrax Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anthrax Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anthrax Vaccines revenues share in global market, 2022 (%)
Key companies Anthrax Vaccines sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Anthrax Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biog?nesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Sant? Animale
Intervac
JOVAC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anthrax Vaccines, market overview.
Chapter 2: Global Anthrax Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Anthrax Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anthrax Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anthrax Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
